Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy is a research paper published in Molecular Therapy Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: K12 CA076930
NCI NIH HHS
Grant: R50 CA274319
NCI NIH HHS
Grant: R21 CA245594
NIDDK NIH HHS
Grant: U54 DK106829
National Institutes of Health
Grant: 5K12CA076930-12
Career Development in Pediatric and Medical Oncology
National Institutes of Health
Grant: 3U54DK106829-03S2
Core Center for Stem Cell and Transplantation Biology
National Institutes of Health
Grant: 1R21CA245594-01
CAR T-Cell Therapy Targeting the Membrane-Proximal C2-Set Domain of CD33 for Treatment of Acute Myeloid Leukemia and Other CD33-Expressing Hematopoietic Neoplasms
National Institutes of Health
Grant: 5R50CA274319-02
Optimizing the Efficacy and Safety of CD33-Targeted Immunotherapy for Acute Myeloid Leukemia and Other CD33+ Disorders
NIDDK
National Cancer Institute
FWCI
1.92
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords